Marsden and Haley
1.18 (s, 42H), 1.17 (21H); 13C NMR (75 MHz, CDCl3) δ 151.4
(2C), 143.4, 143.3, 143.0, 139.0 (2C), 137.1, 133.2, 133.0, 131.1
(2C), 130.6, 127.7, 127.6, 127.2 (2C), 125.4, 124.9, 123.0, 122.9,
122.3 (2C), 121.5 (2C), 106.8, 104.6, 104.5, 100.3, 99.3, 96.4,
96.3, 83.6, 82.8, 80.9, 79.9, 79.1, 78.7, 78.0, 77.9, 35.0 (2C),
31.5 (2C), 18.7 (2C), 18.7, 11.3 (2C), 11.2; IR (KBr) ν 2959,
2864, 2213, 2146, 1593, 1465 cm-1; MS (APCI) m/z (%) 1442.7
(M+ + THF, 30), 1369.8 (M + H+, 100), 1277.8 (25), 1244.8
(20), 1031.2 (10), 225.3 (50).
31.9, 31.5 (2C), 30.3, 29.8, 29.7, 29.6, 29.5, 29.4, 22.7, 14.1; IR
(KBr) ν 2952, 2923, 2195, 2133, 1591, 1478, 826 cm-1; MS
(APCI) m/z (%) 2067.5 (M+ + THF, 40), 1994.7 (M + H+, 20),
1935.8 (40), 1617.2 (80), 1507.5 (100); UV (CH2Cl2) λmax (log ꢀ)
232 (5.24), 324 (5.08), 393 (5.39), 434 (5.24), 453 (5.09).
p-Dibromohexayne. Triyne 10 (612 mg, 1.08 mmol) was
reacted with 1,4-dibromo-2,5-diiodobenzene26 (239 mg, 0.490
mmol) at 40 °C using general in situ deprotection/alkynylation
procedure B (8 h injection, 8 h additional heating). The crude
material was purified by column chromatography (20:1-10:1
hexanes/CH2Cl2) to give the dibromoarene (542 mg, 90%) as a
Key Piece 8. Iodoarene 24 (2.50 g, 1.79 mmol) was reacted
with trimethylsilyl-1,3-butadiyne (328 mg, 2.68 mmol) at 35
°C using general alkyne cross-coupling procedure A (2 h). The
crude material was purified by column chromatography (33:
1-20:1 hexanes/CH2Cl2) to give 8 (1.81 g, 73%) as a brown
1
yellow solid: mp 221-226 °C; H NMR (300 MHz, CDCl3) δ
7.73 (s, 2H), 7.68 (d, J ) 1.5 Hz, 2H), 7.61 (d, J ) 8.3 Hz, 2H),
7.51 (dd, J ) 8.3, 1.5 Hz, 2H), 7.48 (t, J ) 1.5 Hz, 2H), 7.38 (d,
J ) 1.5 Hz, 4H), 1.39 (s, 36H), 1.20 (s, 42H); 13C NMR (75
MHz, CDCl3); δ 151.4, 143.6, 138.9, 137.2, 133.2, 131.1, 127.6,
127.3, 126.2, 124.1, 122.6, 122.4, 121.5, 104.5, 96.5, 84.1, 81.9,
78.9, 77.3, 35.0, 31.5, 18.7, 11.3; IR (KBr) ν 2961, 2864, 2210,
2156, 1593, 1467, 1248, 875, 668 cm-1; MS (APCI) m/z (%)
1293.5 (M+ + THF, 100), 1222.5 (M + H+, 40), 1147.2 (20),
1018.3 (20), 735.5 (40), 447.3 (60).
1
solid: mp 141-145 °C; H NMR (300 MHz, CDCl3) δ 7.68 (d,
J ) 1.8 Hz, 2H), 7.62 (s, 1H), 7.61 (d, J ) 8.4 Hz, 1H), 7.60 (d,
J ) 8.4 Hz, 1H), 7.57 (s, 1H), 7.49 (dd, J ) 8.4, 1.8 Hz, 2H),
7.47 (t, J ) 1.5 Hz, 2H), 7.38 (d, J ) 1.5 Hz, 4H), 1.39 (s, 36H),
1.19 (s, 42H), 1.18 (21H), 0.25 (s, 9H); 13C NMR (75 MHz,
CDCl3) δ 151.4 (2C), 143.4, 143.3, 142.4, 139.0 (2C), 137.1,
137.0, 133.2, 133.1, 131.0 (2C), 127.7, 127.66, 127.6, 127.2 (2C),
125.3, 124.7, 124.5, 122.9, 122.3 (2C), 121.5 (2C), 104.5(2C),
103.1, 99.8 (2C), 96.4, 93.5, 87.6, 83.5, 83.3, 81.1, 80.5 (2C),
79.4, 79.1, 77.9, 76.6, 73.7, 35.0 (2C), 31.5 (2C), 18.7 (2C), 18.6,
11.3 (2C), 11.2, -0.5; IR (KBr) ν 2960, 2865, 2208, 2156, 2099,
p-Diiodohexayne 27. A solution of dibromoarene from
above (400 mg, 0.320 mmol) in dry THF (30 mL) in a flame-
dried flask was cooled to -78 °C under an Ar atmosphere. BuLi
(2.5 M in hexane, 0.40 mL, 1.00 mmol) was added and the
solution was warmed to -40 °C over 10 min after which I2
(254 mg, 1.00 mmol) was added. The solution was brought to
room temperature, stirred for 15 min, and then quenched with
5% NaHSO3 (10 mL). The mixture was diluted with Et2O (30
mL) and washed with 5% NaHSO3 (2 × 30 mL) and H2O (30
mL). The organic phase was dried (MgSO4) and concentrated
in vacuo. The crude material was purified by column chroma-
tography (20:1 hexanes/CH2Cl2) to give 27 (282 mg, 66%) as a
1591, 1458, 847, 668 cm-1; MS (APCI) m/z (%) 1436.8 (M+
+
THF, 30), 1363.7 (M + H+, 100), 1323.7 (10), 1244.8 (10), 767.4
(10), 326.3 (20).
Tri[18]annulene Precursor 25. Key piece 8 (300 mg,
0.215 mmol) was reacted with 1,2-didecyl-4,5-diiodobenzene11d
(60 mg, 0.098 mmol) at 50 °C using general in situ deprotec-
tion/ alkynylation procedure B (8 h injection, 4 h additional
heating). The crude material was purified by column chroma-
tography (15:1 hexanes/CH2Cl2) to give 25 (149 mg, 51%) as a
yellow-brown solid: mp 116-119 °C; 1H NMR (300 MHz,
CDCl3) δ 7.66 (d, J ) 1.5 Hz, 4H), 7.64 (s, 2H), 7.63 (s, 2H),
7.60 (d, J ) 8.4 Hz, 2H), 7.59 (d, J ) 8.4 Hz, 2H), 7.48 (dd, J
) 8.4, 1.5 Hz, 4H), 7.45 (t, J ) 1.5 Hz, 4H), 7.37 (d, J ) 1.5
Hz, 8H), 7.34 (s, 2H), 2.60 (t, J ) 7.6, 4H), 1.62-1.52 (m, 4H),
1.38 (s, 36H), 1.37 (s, 36H), 1.35-1.21 (m, 28H), 1.18 (s, 42H),
1.169 (s, 42H), 1.165 (s, 42H), 0.89 (t, J ) 7.6 Hz, 6H); 13C
NMR (75 MHz, CDCl3) δ 151.4, 151.3, 143.2, 143.2, 142.7,
139.0 (2C), 137.23, 137.21, 137.0, 134.3, 133.2, 133.1, 131.1
(2C), 127.7, 127.6, 127.3, 127.1 (2C), 125.4, 125.1, 124.5, 123.0,
122.3, 122.2, 122.0, 121.5 (2C), 104.6, 104.5, 103.2, 100.0, 99.9,
96.4, 83.5, 83.2, 82.4, 81.0, 80.7, 80.5, 79.8, 79.5, 79.2, 78.1,
78.0, 77.1, 35.0 (2C), 32.5, 31.9, 31.5 (2C), 30.6, 29.7, 29.6,
29.56, 29.5, 29.3, 22.7, 18.7 (3C), 14.1, 11.3 (2C), 11.3; IR (KBr)
ν 2958, 2869, 2205, 2143, 1595, 1478, 836 cm-1; MS (APCI)
m/z (%) 2941.5 (M + H+, 20), 2884.2 (25), 1434.5 (100); UV
(CH2Cl2) λmax (log ꢀ) 264 (5.27), 328 (5.12), 352 (5.12), 383
(5.02).
1
yellow solid: mp 132-135 °C; H NMR (300 MHz, CDCl3) δ
7.94 (s, 2H), 7.70 (d, J ) 1.5 Hz, 2H), 7.63 (d, J ) 8.3 Hz, 2H),
7.52 (dd, J ) 8.3, 1.5 Hz, 2H), 7.49 (t, J ) 1.5 Hz, 2H), 7.40 (d,
J ) 1.5 Hz, 4H), 1.40 (s, 36H), 1.22 (s, 42H); 13C NMR (75
MHz, CDCl3) δ 151.4, 143.5, 142.8, 138.9, 133.2, 131.2, 130.6,
127.6, 127.2, 122.7, 122.4, 121.5, 104.6, 98.9, 96.4, 84.2, 81.9,
81.1, 77.5, 35.0, 31.5, 18.8, 11.4; IR (KBr) ν 2958, 2863, 2209,
2154, 1593, 1461, 876, 831, 668 cm-1; MS (APCI) m/z (%)
1387.2 (M+ + THF, 20), 1315.3 (M + H+, 20), 1291.7 (20),
1261.5 (20), 1177.8 (60), 1102.7 (30), 769.5 (20), 555.2 (100).
Linear Precursor 28. Key piece 8 (400 mg, 0.287 mmol)
was reacted with diiodoarene 27 (176 mg, 0.131 mmol) at 55
°C using general in situ deprotection/alkynylation procedure
B (22 h injection, no additional heating). The crude material
was purified by column chromatography (20:1-10:1 hexanes/
CH2Cl2) to give 28 (267 mg, 57%) as an amorphous yellow
solid: mp 150-155 °C (dec); 1H NMR (300 MHz, CDCl3) δ 7.70
(s, 2H), 7.69 (d, J ) 1.5 Hz, 2H), 7.672 (d, J ) 1.5 Hz, 2H),
7.670 (s, 2H), 7.659 (s, 2H), 7.656 (d, J ) 1.5 Hz, 2H), 7.61 (d,
J ) 8.3 Hz, 4H), 7.60 (d, J ) 8.3 Hz, 2H), 7.52 (dd, J ) 8.3,
1.5 Hz, 4H), 7.49 (dd, J ) 8.3, 1.5 Hz, 2H), 7.47 (t, J ) 1.5 Hz,
6H), 7.40-7.36 (m, 12H), 1.39 (s, 108H), 1.21 (s, 42H), 1.194
(s, 42H), 1.187 (s, 42H), 1.18 (s, 42H); 13C NMR (75 MHz,
CDCl3) δ 151.4 (3C), 143.5, 143.4, 143.3, 139.0 (2C), 138.9,
137.8, 137.2 (3C), 133.3, 133.2, 133.1, 131.1 (3C), 127.7, 127.6
(3C), 127.4, 127.2 (3C), 125.8, 125.6, 125.3, 124.6, 123.0, 122.8,
122.3 (3C), 121.5 (3C), 104.6 (2C), 104.5, 103.1, 100.2, 96.4
(3C), 84.0, 83.7, 83.3, 81.9, 81.5, 81.3, 80.7 (2C), 80.4, 80.0,
79.4, 79.1, 78.8, 78.0, 77.9, 77.8, 35.0 (3C), 31.5 (3C), 18.7 (4C),
11.4 (3C), 11.3; IR (KBr) ν 2958, 2864, 2203, 2151, 1593, 1474,
668 cm-1; UV (CH2Cl2) λmax (log ꢀ) 266 (5.40), 329 (5.28), 351
(5.28), 383 (5.27).
Tri[18]annulene 3. Acyclic precursor 25 (100 mg, 0.0340
mmol) was subjected to both general Cu-mediated cyclization
procedure C and general Pd-catalyzed cyclization procedure
D. The crude material was first dissolved in CH2Cl2, filtered
through a plug of silica gel, and concentrated in vacuo. The
resultant yellow-brown solid was triturated (10:1 hexanes/CH2-
Cl2, 2 × 5 mL) and filtered to give 3 (33 mg, 49% (procedure
C); 14 mg, 21% (procedure D)) as a bright yellow solid: mp
1
230-250 °C (dec); H NMR (500 MHz, CD2Cl2, 40 °C) δ 7.93
(d, J ) 1.5 Hz, 2H), 7.92 (d, J ) 1.5 Hz, 2H), 7.91 (s, 2H), 7.87
(s, 2H), 7.78 (d, J ) 8.0 Hz, 2H), 7.75 (d, J ) 8.0 Hz, 2H), 7.69
(dd, J ) 8.0, 1.5 Hz, 2H), 7.67 (dd, J ) 8.0, 1.5 Hz, 2H), 7.52
(br s, 4H), 7.46 (d, J ) 1.5 Hz, 8H), 7.45 (s, 2H), 2.60 (t, J )
8.0 Hz, 4H), 1.61 (quint, J ) 8.0 Hz, 4H), 1.40 (s, 72H), 1.35-
1.26 (m, 28H), 0.91 (t, J ) 8.0 Hz, 6H); 13C NMR (125 MHz,
CDCl3): δ 151.5 (2C), 143.0, 142.8, 138.4, 138.3, 136.4, 136.2,
133.2, 133.0, 132.9, 131.3, 131.1, 127.7 (2C), 127.6, 125.9,
125.8, 125.5, 125.3, 124.8, 124.1, 123.4, 123.3, 122.6, 122.5,
122.3, 121.4 (2C), 83.2, 82.7, 82.6, 81.6, 81.2, 81.1, 81.05, 81.0,
80.9, 80.8, 79.7 (3C), 79.0, 78.7, 78.6, 78.2, 78.1, 35.0 (2C), 32.4,
Linear Tetra[18]annulene 4. Acyclic precursor 28 (150
mg, 0.0412 mmol) was subjected to both general Cu-mediated
cyclization procedure C and general Pd-catalyzed cyclization
procedure D. The crude material was suspended in CH2Cl2 (50
mL) and filtered through a plug of silica gel. The annulenic
material remained on top of the bed of silica gel was scraped
off and transferred to a beaker of refluxing THF (500 mL).
10224 J. Org. Chem., Vol. 70, No. 25, 2005